Base period and three (3) option periods, labor hour (LH) type task order to procure regulatory support in the research and documentation of data and information to support the review of abbreviated…
Active Awarded Last action
- Contract number
- 75F40125F19005
- Awardee
-
Kaiva Strategies, LLC UEI HCWKVFGBPA64
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $519,856
Award facts
- Contract value 37% obligated
-
- $519,856.38 Current, with exercised options
- $1,423,410.78 Potential, with all options
- Completion date 33% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 541611 Administrative Management and General Management Consulting Services
- PSC
- R499 Support- Professional: Other
- Set-aside
- Competitive 8(a)
- Competition
- Full and Open Competition after exclusion of sources Negotiated Proposal / Quote
- Pricing
- Labor Hours
- Place of performance
- Ivins, UT, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $351,840 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $168,017 |
About this award
The Food and Drug Administration (FDA) awarded a labor hour delivery order valued at $1.42M to Kaiva Strategies, LLC, a tribally-owned, minority-owned small business based in Ivins, Utah. This competitive 8(a) set-aside contract is issued under the FDA's $100M Professional, Administrative, and Consulting Services (PACS) Indefinite Delivery Contract (IDC), which provides flexible mechanisms for the agency to procure specialized regulatory and administrative support services. The task order establishes a base period and three option periods, with an ultimate completion date of April 9, 2029, and was awarded on August 4, 2025. Work will be performed in Ivins, Utah.
Under this delivery order, Kaiva Strategies will provide regulatory support through research and documentation of data and information to assist the FDA's Center for Drug Evaluation and Research in reviewing Abbreviated New Drug Applications (ANDAs). The company's expertise in regulatory support, scientific communication, and medical writing aligns with the FDA's critical mission of ensuring drug safety and efficacy. As a certified 8(a) joint venture and small disadvantaged business, Kaiva Strategies brings substantial experience supporting multiple FDA centers and offices through its existing PACS IDC, having previously delivered services ranging from regulatory review support to administrative assistance across various FDA program areas.
Description
Base period and three (3) option periods, labor hour (LH) type task order to procure regulatory support in the research and documentation of data and information to support the review of abbreviated new drug applications for the FDA's center for
Quick answers
Who was awarded contract 75F40125F19005?
75F40125F19005 was awarded to Kaiva Strategies, LLC by Food and Drug Administration (Department of Health and Human Services) on August 4, 2025.
How much is contract 75F40125F19005 worth?
The government has obligated $519,856 on 75F40125F19005. Its potential value, with all options, is $1,423,411.
Is contract 75F40125F19005 an order under another contract?
Yes. 75F40125F19005 is a delivery order under 75F40123D00021, an indefinite delivery contract.
Was contract 75F40125F19005 competed?
The extent of competition for 75F40125F19005 was full and open competition after exclusion of sources. It was set aside: Competitive 8(a).
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award